Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 11/20 | 0.47 |
| ▸ | CES1 | P23141 | 10/20 | 0.47 |
| ▸ | CES2 | O00748 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | PPARD | Q03181 | 3/20 | 0.39 |
| ▸ | PPARA | Q07869 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL413338 | 1.00 | FAAH (0.47) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL413335 | 1.00 | FAAH (0.47) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL410606 | 1.00 | FAAH (0.47) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL1959306 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL22325578 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL1962801 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2912760 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL2913821 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL1961718 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL1337430 | 0.98 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110049756-B | Oral composition | 狮王株式会社 | 2023-04-04 | — | — | CN | claimed |
| CN-115135307-A | Carrier for cell delivery | 株式会社ITO | 2022-09-30 | — | — | CN | claimed |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | NISSHINBO HOLDINGS INC. (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-4640751-A1 | MARINE BIODEGRADABLE POLYMER PARTICLE GROUPS AND PRODUCTION METHOD FOR SAME | Nisshinbo Holdings Inc. (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12441850-B2 | Amphiphilic alginic acid particle group and method for producing same | NISSHINBO HOLDINGS INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| EP-4608908-A1 | CARBOXYLATE SALTS OF AMINE COMPOUNDS AS CURING AGENTS | Hexcel Corporation (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4589066-A1 | TREATMENT AGENT FOR ACRYLIC FIBERS AND USE OF SAME | Matsumoto Yushi-Seiyaku Co., Ltd. (JP) | 2025-07-23 | — | — | EP | disclosed |
| US-12359146-B2 | Personal cleansing composition comprising a mixture of two polyglycerol fatty acid esters and a sugar fatty acid ester | MERRY PLUS CORPORATION (JP) | 2025-07-15 | — | — | US | disclosed |
| US-20250143993-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2025-05-08 | — | — | US | disclosed |
| WO-2025069893-A1 | CROSSLINKED MARINE BIODEGRADABLE POLYMER COMPOUND COMPRISING DIFFERENT ANIONIC POLYMER COMPOUNDS, AND METHOD FOR PRODUCING SAME | 日清紡ホールディングス株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025023103-A1 | TREATMENT AGENT FOR CARBON FIBER PRECURSOR AND USE THEREOF | 松本油脂製薬株式会社 | 2025-01-30 | — | — | WO | disclosed |
| US-20120021125-A1 | ACRYLIC-FIBER FINISH, ACRYLIC FIBER FOR CARBON-FIBER PRODUCTION, AND CARBON-FIBER PRODUCTION METHOD | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 2012-01-26 | — | — | US | disclosed |
| EP-1909917-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | Showa Denko K.K. (JP) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007013633-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2007-02-01 | — | — | WO | disclosed |
| CN-1294244-C | Biphasic composition induced by polydextrose | UNILEVER PLC (NL) | 2007-01-10 | — | — | CN | disclosed |
| CN-1688683-A | Two-phase composition induced by polydextrose | UNILEVER PLC (NL) | 2005-10-26 | — | — | CN | disclosed |
| CN-1191818-C | Cleaning products with improved moisturization | PROCTER & GAMBLE (US) | 2005-03-09 | — | — | CN | disclosed |
| CN-1505663-A | Polyorganosiloxane emulsion composition and a cosmetic material made therefrom | ������������ʽ���� | 2004-06-16 | — | — | CN | disclosed |
| CN-1469731-A | Multi-phase separating personal wash composition in transparent or translucent package | — | 2004-01-21 | — | — | CN | disclosed |
| CN-1261789-A | Cleaning products having improved moisturization properties | PROCTER & GAMBLE (US) | 2000-08-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250143993-A1 | COSMETIC | SLC7A1, SLC14A1, H1-0 | FAAH 2182/4885CES1 961/4885CES2 1060/4885 |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | ALG3, ALG1, HACD3 | FAAH 2324/4885CES1 3472/4885CES2 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.